Search This Blog

HIV prevention drugs could halve new cases, aid women

HIV prevention drugs could halve new cases, aid women
- The ASPIRE trial, being undertaken by the Microbicide Trials Network, is
testing the efficacy and safety of delivering a monthly vaginal ring
having dapiravine, an ARV, in 2,600 young HIV-negative women from
Malawi, South Africa, Uganda and Zimbabwe